Drug Shortage Report for APO-DILTIAZ CD
Report ID | 76714 |
Drug Identification Number | 02230999 |
Brand name | APO-DILTIAZ CD |
Common or Proper name | DILTIAZEM CD |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | DILTIAZEM HYDROCHLORIDE |
Strength(s) | 240MG |
Dosage form(s) | CAPSULE (CONTROLLED-DELIVERY) |
Route of administration | ORAL |
Packaging size | 100 BTL |
ATC code | C08DB |
ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-02-20 |
Estimated end date | 2019-07-19 |
Actual end date | 2019-07-11 |
Shortage status | Resolved |
Updated date | 2019-07-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-02-24 | English | Compare |
v2 | 2019-02-24 | French | Compare |
v3 | 2019-04-11 | English | Compare |
v4 | 2019-04-11 | French | Compare |
v5 | 2019-06-07 | English | Compare |
v6 | 2019-06-07 | French | Compare |
v7 | 2019-07-12 | English | Compare |
v8 | 2019-07-12 | French | Compare |
Showing 1 to 8 of 8